Stay updated on ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.2 to v3.5.3, reflecting a new template release. It does not change the displayed study details or layout for users.
    Difference
    0.0%
    Check dated 2026-04-30T14:11:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0. This appears to be a minor site update with no changes to study records.
    Difference
    0.0%
    Check dated 2026-04-16T10:34:14.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:44:46.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This indicates a software update rather than substantive content changes on the study page.
    Difference
    0.0%
    Check dated 2026-03-11T14:33:15.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the long funding-status notice and Revision: v3.4.1. The update does not affect the study details or how the page is used.
    Difference
    0.3%
    Check dated 2026-02-11T02:17:31.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and NIH CC operations. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T01:17:54.000Z thumbnail image

Stay in the know with updates to ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.